enhanced expression in the neointima 14-21 days after injury. Furthermore, Cre-recombinase-IRES-GFP plasmid delivered by targeted US reduced CRT expression in the neointima of CRT-floxed mice and led to a significant reduction in neointima formation and collagen deposition. The neointimal cell number was also reduced in mice, with a local, tissue-specific knockdown of CRT. Conclusions: This work establishes a novel role for CRT in mediating VSMC responses to injury through the regulation of collagen deposition and neointima formation.
Introduction
Neointimal thickening is a hallmark of vascular responses to injury, both in acute injury following percutaneous coronary intervention and in response to chronic vascular injury in atherosclerosis. Neointima formation is characterized by medial vascular smooth-muscle cell (VSMC) proliferation and migration from the media to the neointima, and by acquisition of the synthetic pheno-type with enhanced expression of extracellular matrix (ECM) components, including type I collagen, which leads to vessel occlusion [1] [2] [3] .
TGF-β is increased following vascular injury and plays a role in neointima formation [4] . Canonical TGF-β signaling occurs following TGF-β binding to the type II/type I receptor complex, leading to the phosphorylation of Smad2/3, complex formation with Smad4 and migration into the nucleus to regulate gene transcription. Introduction of a plasmid encoding TGF-β or recombinant TGF-β enhances ECM production by VSMCs and promotes intimal thickening [5, 6] . Furthermore, blockade of TGF-β with antibodies or a soluble TGF-β decoy receptor significantly attenuates neointima formation [7, 8] . Blockade of TGF-β-induced Smad signaling using adenoviral delivery of inhibitory Smad 7 attenuates neointimal formation and collagen production [9] . The role of TGF-β in VSMC proliferation is more controversial. Halloran et al. [10] demonstrated that TGF-β inhibits human arterial SMC proliferation, whereas other studies show that TGF-β stimulates VSMC proliferation through Smad3 and ERK-dependent pathways [11, 12] .
Endoplasmic reticulum (ER) stress is becoming appreciated as an important factor in fibroproliferative disease, including vascular disease [13] [14] [15] . Calreticulin (CRT) is a calcium-binding protein in the ER lumen that regulates ER calcium stores and downstream calcium-dependent signaling pathways; it also regulates protein folding as part of the CRT-calnexin pathway, acts as a chaperone, and participates in the unfolded protein response [16] [17] [18] . CRT is upregulated in the aortic arch of streptozotocin-treated hamsters and in the endothelium and media of atherosclerotic arteries of rabbits fed a high-fat diet [19, 20] . It is critical for the development of fibrotic disease in multiple organs. It is upregulated in the unilateral ureteral obstruction model of tubulointerstitial fibrosis [21] . Mice heterozygous for CRT have reduced collagen production following unilateral, ureteral obstruction-induced injury when compared to wild-type mice [22] . CRT can also regulate SMC proliferation as siRNA knockdown of CRT inhibits PDGF-bb-stimulated bronchiolar SMC proliferation [23] . Furthermore, our laboratory established that CRT is a critical regulator of ECM production in response to TGF-β, establishing a key mechanistic link between ER stress and fibrosis [24, 25] . Mouse embryonic fibroblasts (MEFs) from CRT-null mice have reduced type I and type III collagen, fibronectin transcript and protein [24] . In addition, cells deficient in CRT are unable to induce ECM production in response to TGF-β, even in the presence of enhanced ER stress and active Smad signaling [25] . CRT regulates TGF-β-stimulated ECM production through the control of ER calcium release and the downstream activation of calcineurin/ NFAT signaling [25] . Inhibition of calcineurin/NFAT signaling impairs TGF-β-stimulated ECM production in several fibroblast cell lines, illustrating the importance of CRT-mediated calcineurin/NFAT signaling in TGF-β-induced ECM production [25] .
Genetic deletion of the CRT gene (calr) results in embryonic lethality, so it has been difficult to experimentally determine the role of CRT in disease in adult animals. In our current studies, we used the carotid artery ligation mouse model of acute vascular injury in newly available CRT-floxed mice, in order to determine whether CRT is involved in regulating vascular responses to injury and neointima formation [26] [27] [28] . We used a targeted ultrasound (US) approach to deliver Cre-recombinase plasmid with microbubbles (MB) to the carotid arteries of CRT-floxed mice to knock down CRT expression specifically in this tissue [29] [30] [31] [32] [33] [34] . We observed that knockdown of CRT in the carotid artery significantly reduces neointima formation and neointimal collagen [27] . This study demonstrates that CRT plays an important role in regulating VSMC responses to acute injury, and it suggests the potential utility of targeting CRT for the treatment of vascular disease.
Materials and Methods

Chemicals and Reagents
Dulbecco's modified Eagle's medium (DMEM) with 1 g/l glucose was purchased from Invitrogen (Madison, Wis., USA). Protease inhibitor cocktail and ionomycin (cat. No. I0364) were purchased from Sigma (St. Louis, Mo., USA). D-PBS was purchased from Cellgro (Manassas, Va., USA). 11R-VIVIT was purchased from CalBiochem (Billerica, Mass., USA). TGF-β was purchased from R&D Systems (Minneapolis, Minn., USA). Rabbit anti-β-tubulin (cat. No. 9104) was purchased from Santa Cruz Biotechnology (Santa Cruz, Calif., USA 
CRT-Floxed Mice
All protocols were approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham and were consistent with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. CRTfloxed mice on the B6D2F1 background were generated by Tokuhiro et al. [35] . Ten-to 14-week-old CRT-floxed mice were maintained at a constant humidity (60 ± 5%), temperature (24 ± 1 ° C) and light cycle (6: 00 a.m. to 6: 00 p.m.). They were fed a standard pellet diet ad libitum. The presence of loxP sites in male and female breeders was confirmed by PCR (online suppl. fig. 1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000443884). The functionality of loxP sites was confirmed by using Cre-recombinase-IRES-GFP to knock down CRT in cells receiving the plasmid ( fig. 1 a, b) .
Plasmid Delivery via Targeted US Treatment with MB Injection
CRT-floxed mice were injected via the tail vein with a solution containing 200 μl of Optison MB (approx. 1.2 × 10 8 ) and either 300 μg of GFP plasmid or Cre-recombinase-IRES-GFP plasmid in a total volume of 250 μl (n = 7 mice/group). As a technical control for the effects of US, mice were injected with Cre-recombinase-IRES-GFP with MB but without US treatment (n = 3). In pilot studies, plasmid was delivered with 50 μl of Optison MB. Immediately following tail-vein injection, US was performed on both carotid arteries. As previously detailed [36] , the custom experimental US setup involved a single-element (0.75-inch) immersion transducer (Olympus, Waltham, Mass., USA) in series with a signal generator (AFG3022B, Tektronix, Beaverton, Oreg., USA) and power amplifier (A075, Electronics and Innovation, Rochester, N.Y., USA). This study was completed using the following acoustic parameters: a 1.0-MHz US frequency, 0.7-MPa peak negative pressure, 30-second pulse repetition period and 2-min duration of exposure.
GFP Plasmid Delivery Pilot Study
To determine the effectiveness of plasmid delivered using targeted US, CRT-floxed mice injected with 300 μg of GFP plasmid and MB (150 μl total) were subjected to US, targeting the carotid arteries as above. Arteries were harvested at 1, 3, 7 and 14 days following plasmid/MB injection with US treatment. Mice (n = 2/ group) were euthanized, perfused with PBS, and the carotid arteries harvested and frozen in OCT. Longitudinal cryostat sections of the right carotid artery were fixed with acetone and then immunostained for GFP or PECAM1. Sections were blocked with filtered PBS containing 4% BSA and 2% mouse serum followed by rabbit anti-GFP (1: 500) and rat anti-PECAM1 (1: 100) diluted in blocking buffer. After overnight incubation, sections were washed with PBS and incubated with goat anti-rabbit Alexa Fluor 555 (1: 500) or goat anti-rat 488 (1: 500) secondary antibodies for 1 h at room temperature. Sections were washed in PBS and stained with Hoechst dye to stain DNA, a nuclear marker, for 5 min. Coverslips were mounted with Fluoromount-G mounting media and stored at 4 ° C. Vessel images were obtained using a ×40 objective.
Carotid Artery Ligation
One week following US delivery of plasmid with MB, mice were anesthetized with1.5% isofluorane in oxygen and the right common carotid artery was exposed through a midline cervical incision and ligated with a 6-0 silk suture just proximal to the bifurcation as previously described [37] . The left carotid artery was not ligated and served as an internal control.
Carotid Artery Harvesting and Morphometric Analysis
Three weeks after the carotid artery ligation, mice were anesthetized with ketamine (80 mg/kg i.p.; Abbott Laboratories, Abbott Park, Ill., USA) and xylazine (5 mg/kg i.p.; Rompun, Bayer Corp., Leverkusen, Germany). The vasculature was immediately flushed with 0.01 M of sodium phosphate buffer (pH 7.4) and perfused with 10% formalin. Both carotid arteries were excised, fixed in 10% formalin for 24 h, embedded in paraffin, and sectioned. Representa- Fig. 1 . Knockdown of CRT in VSMCs isolated from CRT-floxed mice inhibits TGF-β-stimulated collagen production. a , b VSMCs were isolated from CRT-floxed mice, transfected with 1 μg GFP or Cre-recombinase-IRES-GFP, and grown overnight in media with 10% FBS. The cells were switched to serum-free DMEM for the remainder of the experiment. a After 96 h, cell lysates were immunoblotted for CRT and normalized to β-tubulin (3 separate experiments). A representative blot is shown. b After 72 h, RNA was harvested by TRIZOL, and transcript levels of C alr and S9 were determined by quantitative real-time PCR (3 separate experiments). c CRT-floxed VSMCs were transfected with 1 μg GFP or Cre-recombinase-IRES-GFP plasmid, grown overnight in DMEM with 10% FBS and then switched to serum-free DMEM for 24 h. Cells were treated with 100 p M TGF-β for 48 h and cell lysates immunoblotted for CRT and type I collagen. A representative blot is shown. Densitometric analyses represent mean density normalized to β-tubulin (indicated above the bands) ± SD (3 separate experiments). * p < 0.05 versus GFP-transfected cells. Cre = Cre-recombinase-IRES-GFP plasmid; n.s. = not significant.
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309 tive serial sections were stained with hematoxylin and eosin (HE) and examined under a light microscope to locate the ligation site. Then additional sections of the artery taken 350, 500 and 700 μm proximal to the ligation site were identified and treated with Verhoeff's elastin stain to visually enhance the elastic laminae.
Three tissue sections corresponding to the upper, middle and lower portion of the carotid artey from each mouse were used for immunohistochemistry staining and determination of GFP or CRT expression. Computer-assisted morphometric analysis of digitized images captured from each arterial section was per- formed with ImageJ analysis software. Measurements of the 3 sections obtained for each vessel were averaged for statistical purposes. The cross-sectional area of the media (i.e. the zone bounded by the external and internal elastic laminae) and the area of the intima (i.e. the zone between the internal elastic lamina and the lumen) were calculated using ImageJ. All measurements were performed by a single examiner blinded to the treatment group.
CRT Expression following Carotid Injury
To determine CRT expression in the vasculature following carotid artery ligation, the right common carotid arteries of CRTfloxed mice were ligated as described above. They were harvested on days 3, 7, 14 and 21 following ligation (n = 3, days 3-14 and n = 4, day 21). Formalin-fixed vessels were sectioned and immunostained for CRT using the rabbit monoclonal anti-CRT antibody as described below.
Isolation of CRT-Floxed Mouse VSMCs
Mouse VSMCs were isolated from CRT-floxed mice as previously described [38] . Briefly, mouse aortas were harvested, adventitia removed, and cells were digested with 1× collagenase for 30 min. The aorta was cut to to 1-mm pieces and cells were allowed to grow out of the explant for 2 weeks in low-concentration (1 g/l) glucose DMEM with 10% FBS. Cell outgrowths were removed and passaged using trypsin. For all experiments, cells were used between passages 3 and 7.
Knockdown of CRT in CRT-Floxed VSMCs
CRT-floxed VSMCs (500,000 cells) were transfected via nucleofection using the primary VSMC nucleofector kit from Amaxa Biosystems (Amaxa GmbH, Lonza) in an Amaxa Nucleofector II using the program P-024. Transfected cells were cultured in DMEM (1 g/l glucose) with 10% FBS for 24 h. After 24 h, media was switched to serum-free media for 24 h, followed by treatment with 100 p M TGF-β for 48 h.
Immunoblotting
Following treatment, cells were harvested using 1× Laemmli lysis buffer (Bio-Rad, Hercules, Calif., USA) containing 1× protease inhibitor cocktail (Sigma cat. No. p8340). Cells were sonicated for 7 s, a 5% final concentration of β-mercaptoethanol was added and the samples were boiled at 100 ° C for 7 min. Samples were centrifuged and equal volumes were loaded onto 4-15% SDS-polyacrylamide gels. After separation by SDS-PAGE, samples were transferred onto a PVDF membrane at 100 V for 100 min. Following transfer, membranes were blocked with 1% casein followed by application of the primary antibody. Membranes were washed in TBS-T (0.05% Tween) and secondary antibody was applied for 1 h at room temperature. Membranes were washed with TBS-T and developed using Western Lightning Chemiluminescence Reagent Plus. Membranes were probed with rabbit anti-β-tubulin IgG to normalize for cell protein. Densitometric analyses of immunoblots were performed using the NIH ImageJ program. Data are expressed as the mean (± SD) band density normalized for cell protein from at least 3 separate experiments.
Quantitative Real-Time PCR Cells were grown overnight in complete media containing 10% FBS and then in serum-free media for 72 h. After treatment, RNA was harvested with TRIZOL reagent and isolated according to the manufacturer's specification. Quantitative real-time PCR was performed using standard protocols with an Opticon instrument (MJ Research, model CFD-3200, Quebec, Ont., Canada). Primers for Calr (cat. No. QT00101206) and S9 (cat. No. PPM03695A) were purchased from Qiagen and verified by melt-curve analysis. Transcript levels were assayed using SYBR green (Qiagen; Venlo, The Netherlands). Results were calculated using the ΔΔCT method and are expressed as the mean ± SD of 3 samples, each assayed in triplicate as indicated in the figure legends. Results are representative of at least 3 separate experiments.
Immunohistochemistry Formalin-fixed, paraffin-embedded carotid artery sections were used for immunohistochemistry. Briefly, antigen retrieval was performed on deparaffinized slides using 10 m M sodium citrate buffer (pH 6.0) in a 100 ° C water bath for 20 min, followed by cooling for 20 min. Endogenous peroxidase activity was quenched with 1% hydrogen peroxide in PBS. Tissues were blocked with 2% normal horse serum (Sigma) for 30 min. Slides were incubated with rabbit monoclonal anti-CRT IgG (1: 1,000) or rabbit antiKi67 IgG (1: 1,000) diluted in PBS with 2% horse serum and 0.1% Triton X-100 overnight at 4 ° C. Sections incubated with nonimmune IgG served as a negative control. After washing in PBS with 0.1% Tween-20, appropriate biotinylated secondary antibodies, i.e. biotinylated goat anti-rabbit IgG (1: 250) (Vector Laboratories, Burlingame, Calif., USA), were applied to the tissue for 1 h at room temperature, followed by HRP-conjugated streptavidin (ABC kit, Vector Laboratories) for 1 h at room temperature at dilutions recommended by the manufacturer. Processed sections were developed with 3,3 ′ -diaminobenzidine hydrochloride (DAB, Vector Laboratories) and then counterstained with hematoxylin QS (Vector Laboratories). After dehydration, the slides were mounted in VectaMount mounting medium (Vector Laboratories). Images of CRT-stained sections were taken using a Zeiss Axiovert 10 inverted microscope and a positive stain was determined using Metamorph Imaging Software. Specificity of the rabbit monoclonal antibody to CRT was confirmed by immunoblot of cell lysates from wild-type and CRT-null MEFs (online suppl. fig. 2 ).
For analysis of the CRT stain in the paraffin-embedded sections, images were obtained with a ×20 objective, and total cellular CRT stain in the neointima and medial area was quantified using Metamorph Imaging Software. To normalize the CRT stain to neointimal area, the neointimal area for each section was calculated using imageJ software. Analysis was performed on all mice used in the study.
For analysis of Ki67-positive nuclei, images of the entire neointima were taken and the number of Ki67-positive cells in each neointima was counted and divided by the total number of nuclei. For each field of view, at least 100 total nuclei were counted. The observer was blinded to the treatment groups.
Trichrome stain and Verhoeff's elastin stain were performed by the Comparative Pathology Laboratory core facility according to standard procedures.
Statistics
For in vitro studies, the one-way ANOVA of rank sums was used to analyze data with multiple groups and the Student t test to compare means between 2 groups. For animal studies, data were analyzed using the Mann-Whitney U rank-sum test. SigmaStat and GraphPad Prism were used for statistical analyses. Results were considered significant if p < 0.05.
Results
Cre-Recombinase-IRES-GFP Plasmid Reduces CRT Transcript and Protein in VSMCs from CRT-Floxed Mice
Mice with the Calr gene flanked by LoxP sites at exons 4 and 7 were generated as described [35] . PCR was performed on DNA from wild-type and CRT-floxed mice using primers specifically designed to detect the presence of LoxP sites. DNA isolated from CRT-floxed male and female mice generated a 400-bp band with the CRT-floxed primers, but no band was produced with DNA isolated from wild-type mice (online suppl. fig. 1 ). VSMCs isolated from CRTfloxed mice were transfected with GFP or Cre-recombinase-IRES-GFP plasmid and the levels of Calr transcript or protein were determined 72 or 96 h after transfection, respectively. Transfection with Cre-recombinase-IRES-GFP reduced the Calr transcript and protein by approximately 60% ( fig. 1 a, b) , confirming that excision of exons 4-7 of Calr ablates CRT protein expression in transfected cells.
Knockdown of CRT in VSMCs Significantly Impairs TGF-β-Stimulated Collagen Production
CRT is a critical regulator of TGF-β-stimulated ECM production including collagen and fibronectin in fibroblasts [25] . Therefore, we investigated the effect of CRT knockdown on TGF-β-induced collagen production in VSMCs isolated from CRT-floxed mice. Delivery of Crerecombinase-IRES-GFP to CRT-floxed VSMCs reduced CRT expression by 40% and significantly attenuated TGF-β-stimulated collagen production ( fig. 1 C) .
TGF-β Stimulation of Collagen Protein in VSMCs Is
Partially NFAT-Dependent CRT regulates TGF-β-stimulated ECM production in fibroblasts through control of calcineurin/NFAT signaling [25] . Calcineurin is a serine-threonine phosphatase responsible for dephosphorylation of the transcription factor NFAT, allowing NFAT to translocate to the nucleus [17] . Inhibition of calcineurin/NFAT signaling with 11R-VIVIT, a cell-permeable peptide which blocks calcineurin binding to NFAT, blocked increases in TGF-β-stimulated collagen and fibronectin transcripts in fibroblasts [39] . In CRT-floxed VSMCs treated with 11R-VIVIT, TGF-β stimulation of type I collagen protein was reduced by approximately 50% ( fig. 2 a) . 11R-VIVIT also completely inhibits the TGF-β-stimulated Col1a1 transcript and protein in rat VSMCs (online suppl. fig. 3 ). CRT regulation of TGF-β collagen stimulation appears to occur via similar mechanisms in both fibroblasts and VSMCs.
CRT Expression and Collagen Is Upregulated in the Neointima following Carotid Artery Ligation
These studies on isolated VSMCs suggest that CRT regulates TGF-β stimulation of collagen I production. As TGF-β regulates VSMC-mediated ECM production and neointimal hyperplasia in vivo [5, 6] , we asked whether CRT expression is altered following acute vascular injury in the carotid artery ligation model. In the uninjured artery, intracellular CRT expression is limited to the media and endothelium (data not shown). At day 3 following injury, CRT expression is primarily in the endothelium and adventitia with minimal staining in the medial layer ( fig. 3 a) . By day 7, neointimal formation is beginning and CRT staining is observed in these regions. At days 14 and ( fig. 3 a) . Medial expression of CRT is also increased, but to a lesser extent than in the neointima. The expression of fibrillary collagens as detected by Masson's trichrome stain shows a similar increase in neointimal collagens at days 14 and 21 ( fig. 3 b) . These results suggest that CRT expression is elevated in regions of vascular remodeling in which fibrillary collagen expression is upregulated.
Targeted US Can Deliver Plasmid to the Vascular
Wall siRNA, therapeutic drugs or plasmid DNA can be selectively delivered to tissues through the use of MB with US, which effectively transfects cells in targeted areas via sonoporation [29] [30] [31] [32] [33] [34] . US triggers the expansion and compression of gas-filled, albumin-shelled MB (Optison TM ), thereby generating microjets capable of inducing shear stress and membrane pores which facilitate plasmid delivery [40, 41] . In pilot studies, we delivered 300 μg of GFP plasmid mixed with MB via US-targeted delivery to the carotid artery of uninjured CRT-floxed mice, and examined GFP expression in the carotid arteries at 1, 3, 7 or 14 days following treatment by immunofluoresence ( fig. 4 ) . Expression of GFP in the media was observed at day 1 following plasmid delivery, with maximal expression at day 3. Medial staining for GFP was detectable for at least 14 days. These studies indicate that delivery of plasmid to the vascular wall is feasible through targeted US. Therefore, delivery of plasmid with MB and US treatment was conducted 7 days prior to carotid artery ligation to ensure a reduction of CRT protein prior to vascular injury.
US Delivery of Cre-Recombinase-IRES-GFP Plasmid with MB Reduces Neointimal CRT following Carotid Artery Ligation
Delivery of the Cre-recombinase-IRES-GFP leads to genetic deletion of the CRT gene and persistent CRT ablation in cells receiving the plasmid. We used targeted US to deliver Cre-recombinase plasmid to the carotid arteries 7 days prior to carotid artery ligation, with the goal of specifically reducing medial CRT expression prior to injury. Carotid arteries were harvested 21 days following carotid artery ligation and sections (500-550 μ M) obtained from the ligation site were evaluated for CRT protein by immunohistochemistry. Strong immunostaining for CRT was observed in cells in the neointima of mice receiving GFP plasmid or Cre-recombinase-IRES-GFP plasmid with MB, but without US ( fig. 5 a) . In contrast, CRT staining was markedly reduced in the neointima of carotid arteries from mice receiving the Cre-recombinase-IRES-GFP plasmid with MB and US treatment ( fig. 5 a-c) . Overall neointimal CRT was reduced by nearly 75% and approximately 40% when normalized to the neointimal area in mice receiving Cre-recombinase-IRES-GFP compared to mice receiving GFP control plasmid ( fig. 5 b, c) . Because there was a slight, but not significant, reduction in cellular CRT staining in mice receiving Cre-recombinase-IRES-GFP with MB without US, we cannot rule out the possibility of a low level of transfection in the absence of US.
Knockdown of CRT with Cre-Recombinase-IRES-GFP Reduces Neointima Formation following Vascular Injury
To determine the effect of CRT knockdown on neointima formation, morphometric analysis was performed on carotid artery sections 3 weeks following injury. The neointimal area and neointima-to-media ratio of injured vessels was reduced by 50% in mice receiving the Crerecombinase-IRES-GFP plasmid compared to mice receiving the control GFP plasmid or the Cre-recombinase plasmid with MB but no US ( fig. 6 a, c, d) . In contrast, the medial area did not differ between groups ( fig. 6 b) . Furthermore, mice receiving Cre-recombinase-IRES-GFP plasmid with MB/US had fewer cells in the neointima compared to controls ( fig. 6 e) .
Knockdown of CRT with Cre-Recombinase-IRES-GFP Reduces Neointimal Collagen
Since CRT knockdown inhibited TGF-β-stimulated collagen production in CRT-floxed VSMCs, we wondered whether CRT knockdown affected collagen levels in the neointima. Analysis of Masson's trichrome-stained carotid artery sections showed that mice treated with Crerecombinase-IRES-GFP with MB/US displayed reduced neointimal collagen and collagen content/neointimal cell numbers compared to mice treated with GFP plasmid with MB/US or Cre-recombinase-IRES-GFP with MB but no US ( fig. 7 a-c) .
Discussion
The ER stress protein CRT is involved in fibrotic disease and atherosclerotic plaque formation. CRT is upregulated in a model of renal tubular injury which develops tubulointerstitial fibrosis [21] . Furthermore, CRT-heterozygous mice have reduced fibrosis following renal tubular injury and reduced type I and III collagen, fibronectin and TGF-β transcript [22] . Treatment of the APA strain of hamster with streptozotocin to induce diabetes is a model used to induce atheromatous lesions in the aortic arch; in this model, CRT expression is significantly increased and promotes atherosclerotic lesion formation, suggesting that CRT is involved in atherosclerosis [19] . We also observed strong CRT immunostaining in aortic lesions from ApoE-null mice, a model that develops atherosclerotic lesions upon feeding a high-fat diet [42] (data not shown), and our current studies show CRT abundantly expressed in the neointima following carotid artery ligation.
We previously demonstrated that CRT is a critical regulator of TGF-β-stimulated ECM production in fibroblasts, providing initial mechanistic insight into how ER stress exacerbates fibrotic disease. Our data now demonstrate that knockdown of CRT in vivo significantly inhib- its carotid artery ligation-induced neointima formation and neointimal collagen deposition, suggesting that CRT is a critical component of vascular disease. These studies report the first in vivo data utilizing CRT-floxed mice as a model and also provide further evidence that CRT is required for the progression of fibrotic disease in vivo. High levels of CRT staining are present in the neointima following carotid artery ligation, suggesting an important role for CRT in response to vascular injury. To our knowledge, this is the first evidence that CRT is increased in response to acute vascular injury and that it plays a causal role in vascular disease.
Previously, we showed that cells deficient in CRT have attenuated TGF-β-stimulated collagen and fibronectin production due to impaired TGF-β-stimulated calcium release and downstream calcineurin/NFAT signaling, suggesting a mechanism by which CRT regulates fibrotic disease [25] . To address the mechanism by which CRT regulates neointima formation and collagen deposition in vivo, studies were performed on VSMCs isolated from CRT-floxed mice: CRT knockdown inhibited TGF-β-stimulated collagen production. Furthermore, TGF-β stimulation of collagen in rat and floxed-mouse VSMCs is attenuated by the NFAT inhibitor 11R-VIVIT, suggesting that CRT regulates TGF-β-induced collagen production in VSMCs through control of NFAT signaling, as in fibroblasts [25] . Consistent with this idea are observations that inhibition of NFAT activation with cyclosporine or GFP-VIVIT significantly attenuates balloon injury-induced neointima formation in rats and that inhibition of calcineurin signaling impairs highglucose-stimulated ECM production in mice [43, 44] . The high-glucose-induced ECM production in this study was suggested to occur through the release of extracellular nucleotides leading to the downstream activation of the calcineurin/NFAT pathway that leads to the induction of the ECM protein osteopontin [44] . Interestingly, despite the inhibitory effect of calcineurin/ NFAT inhibitors on TGF-β-stimulated ECM production, the addition of the calcium ionophore, ionomycin, at concentrations sufficient for inducing NFAT reporter activity in MEFs (data not shown) was not enough to rescue CRT-deficient MEFs unresponsive to TGF-β stimulation [25] . Similar results were observed in ionomycin and TGF-β-treated CRT-floxed mouse VSMCs with 40% CRT knockdown (data not shown). These data suggest that, while NFAT activity is required for TGF-β-induced ECM production, other factors regulated by CRT, likely independent of ER calcium release and NFAT activity, are also involved.
Interestingly, knockdown of CRT with Cre-recombinase-IRES-GFP reduced neointimal cell numbers 21 days after injury, suggesting that, in addition to regulating VSMC ECM production, CRT might also regulate neointima formation through the control of VSMC proliferation. However, we failed to observe differences in the Ki67-positive nuclei at 21 days following injury with CRT knockdown (data not shown). Although most VSMC proliferation in the carotid artery ligation model occurs between days 7 and 14 [27] , our negative data at 21 days, combined with results from in vitro studies, showing that CRT knockdown did not significantly alter cell proliferation in response to either 10% FBS or to the modest stimulation by TGF-β (online suppl. fig. 4 ), suggest that CRT does not play a major role in regulating VSMC proliferation in this model [27] . It is possible that the reduced neointimal cell number is the result of impaired cell migration. This could be due to the direct effects of CRT (cell surface or ER CRT) on cell migration or to indirect effects as a result of decreased ECM expression; e.g., type I collagen and fibronectin induce the migration of VSMCs [22, [45] [46] [47] [48] .
Apart from its role in the ER, CRT has important functions at the cell surface [20] . It is not known whether CRT knockdown affects apoptotic cell clearance by cell surface CRT in injured carotid arteries. CRT protein infusion into the iliofemoral arteries prior to balloon injury reduces neointimal hyperplasia and medial macrophages and T cell numbers [49] . In atherosclerotic models with a reduced expression of CRT, there is impaired clearance of apoptotic bodies by macrophages, resulting in increased foam-cell formation and inflammatory cytokines [50] . However, foam-cell formation is not a major factor in this acute vascular injury model. Nonetheless, the role of CRT in vascular inflammation remains to be fully explored.
Genetic deletion of the Calr gene results in embryonic lethality due to altered cardiac development, and embryonic fibroblasts isolated from these embryos display impaired agonist-induced calcium release and NFAT nuclear translocation [18] . Therefore, it is difficult to experimentally determine the role of CRT in disease in adult animals, although heterozygous mice are viable to adulthood [22] . Mice with homozygous, floxed CRT alleles can now be used to determine the cell-and tissue-specific roles of CRT in adult mice. Indeed, these current studies are the first to specifically target the Calr gene in one tissue. US-targeted delivery of Cre-recombinase-IRES-GFP with MB was used to specifically target knockdown of CRT in the carotid artery. Since the majority of cells in the neointima following injury are derived from medial VSMCs, it is conceivable that knockdown of CRT in a minority of medial cells in the uninjured media is sufficient to impact neointima formation and collagen deposition following injury. Our results clearly demonstrate that US-targeted delivery of Cre-recombinase-IRES-GFP plasmid results in sufficient CRT knockdown to observe a biological effect. This is consistent with observations that mice heterozygous for CRT have significantly reduced fibrosis and improved kidney function in models of renal injury [22] .
In conclusion, these studies establish the importance of CRT in vascular responses to injury and demonstrate that CRT is a critical regulator of neointima formation and collagen production in vivo.
